Pinnacle Wealth Management Advisory Group, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1631864 RED BANK, NJ

Position in VRTX

as of Mar 31, 2026 · filed Apr 21, 2026 Compact

Position Value

$390,275

+$36,655 QoQ

Shares Held

874

+12.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Pinnacle Wealth Management Advisory Group, LLC holds $3,780,035 across 11 Biotechnology names. VRTX ranks #2 (10.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,415	$1,865,925
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	874	$390,275
3	BMRN	Biomarin Pharmaceutical Inc	6,115	$345,436
4	INCY	Incyte Corp	3,443	$324,055
5	PRAX	Praxis Precision Medicines, Inc.	744	$239,709
6	EXEL	Exelixis, Inc.	5,195	$222,813
7	ABVX	Abivax S.A.	1,864	$207,556
8	GERN	Geron Corp	44,466	$66,254

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$390,275	874	+12.1%	Shares	Sole	2026-04-21
2025-12-31	$353,620	780	+2.0%	Shares	Sole	2026-02-02
2025-09-30	$299,604	765	+1.1%	Shares	Sole	2025-10-20
2025-06-30	$337,016	757	+3.6%	Shares	Sole	2025-08-07
2025-03-31	$354,403	731	+6.6%	Shares	Sole	2025-05-07
2024-12-31	$276,252	686	-3.5%	Shares	Sole	2025-01-31
2024-09-30	$330,671	711	+0.4%	Shares	Sole	2024-10-16
2024-06-30	$331,853	708	+4.9%	Shares	Sole	2024-07-25
2024-03-31	$282,156	675	+3.8%	Shares	Sole	2024-05-01
2023-12-31	$264,478	650	0.0%	Shares	Sole	2024-02-07
2023-09-30	$226,031	650	-1.5%	Shares	Sole	2023-10-25
2023-06-30	$232,260	660	-5.7%	Shares	Sole	2023-08-02
2023-03-31	$220,549	700	—	Shares	Sole	2023-05-04
No filing history on record for this holder in this stock.